S Strandgaard
Overview
Explore the profile of S Strandgaard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
124
Citations
1688
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frimodt-Moller M, Nielsen A, Kamper A, Strandgaard S
Scand J Clin Lab Invest
. 2006 Aug;
66(5):385-94.
PMID: 16901849
Objective: Applanation tonometry for pulse-wave analysis (PWA) and determination of pulse-wave velocity (PWV) is a non-invasive method for assessment of the central aortic pressure waveform and indices of arterial stiffness....
2.
Heisterberg J, Kamper A, Sonne J, Strandgaard S, Larsen N
J Renin Angiotensin Aldosterone Syst
. 2002 Mar;
2(4):240-5.
PMID: 11881130
Background: Most angiotensin-converting enzyme (ACE) inhibitors and their metabolites are excreted renally and doses should hence be reduced in renal insufficiency. We studied whether the dosage of enalapril in daily...
3.
Estrup T, Paulson O, Strandgaard S
J Renin Angiotensin Aldosterone Syst
. 2002 Mar;
2(3):188-92.
PMID: 11881121
Blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin AT1-receptor antagonists shift the limits of autoregulation of cerebral blood flow (CBF) towards lower blood pressure (BP). The...
4.
Karlsen F, Strandgaard S
Ugeskr Laeger
. 2001 Aug;
163(33):4418.
PMID: 11521587
No abstract available.
5.
Jensen J, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K
Hypertension
. 2000 Apr;
35(4):898-903.
PMID: 10775558
Albumin excretion in urine is positively correlated with the presence of ischemic heart disease and atherosclerotic risk factors. We studied prospectively whether a slight increase of urinary albumin excretion, ie,...
6.
Hansen J, Johansen N, Mollerup H, Strandgaard S
J Hypertens
. 2000 Feb;
17(12 Pt 1):1707-13.
PMID: 10658936
Objective: The present study investigated whether the nitric oxide (NO) system is involved in cyclosporin A (CsA)-induced changes in cardiovascular and renal function in man. Subjects And Methods: Ten healthy...
7.
Wang D, Iversen J, Strandgaard S
J Vasc Res
. 2000 Jan;
36(6):502-9.
PMID: 10629426
Hypertension and vascular disease are common complications in autosomal-dominant polycystic kidney disease (ADPKD). The role of changes in morphology and reactivity of resistance vessels in this disease have not previously...
8.
Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen J
Arterioscler Thromb Vasc Biol
. 1999 Aug;
19(8):1992-7.
PMID: 10446083
Cross-sectional studies suggest that an increased urinary albumin excretion rate is associated with cardiovascular disease, dyslipidemia, and hypertension. The purpose of this study was to analyze prospectively whether the urinary...
9.
10.
Hansen J, LEYSSAC P, Strandgaard S
Nephron
. 1998 Dec;
80(4):450-7.
PMID: 9832645
The present study evaluated whether chronically administered low-dose (<5 mg/kg) ciclosporin A (CsA) affects renal haemodynamics and tubular function in renal transplant recipients (RTx) when studied at nadir CsA blood...